Org 34517

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, Weill Medical College of Cornell University

Conditions

DepressionDepressive DisordersMajor Depressive DisorderPsychotic Disorders

Phase 2

A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)

CompletedNCT00212797

Merck Sharp & Dohme LLCDepression, Depressive Disorders, Psychotic Disorders

Start: 2004-07-31End: 2006-07-31Updated: 2015-11-26

Safety Study of ORG 34517 for Major Depression With Psychotic Features

CompletedNCT00226278

Weill Medical College of Cornell UniversityMajor Depressive Disorder, Psychotic Disorders

Start: 2004-09-30End: 2005-11-30Target: 25Updated: 2008-03-31